Awareness and Knowledge of Retinoblastoma among Pregnant Women in Nigeria

Arinze Anthony Onwuegbuna *

Department of Ophthalmology, Nnamdi Azikiwe University, Awka, Nigeria.

Akunne Ijeoma Apakama

Department of Ophthalmology, Nnamdi Azikiwe University, Awka, Nigeria.

Emeka Akujuobi Chianakwalam

Department of Ophthalmology, Federal Medical Centre, Umuahia, Nigeria.

Chidiebele Malachy Ezeude

Department of Internal Medicine, Nnamdi Azikiwe University, Awka, Nigeria.

Bernard Chukwunonyerem Ochiogu

Eye Unit, Department of Surgery, Chukwuemeka Odumegwu Ojukwu University, Awka, Nigeria.

Anthonia Chinyelu Udeaja

Eye Unit, Department of Surgery, Chukwuemeka Odumegwu Ojukwu University, Awka, Nigeria.

Chisom God’swill Chigbo

School of Public Health, University of Port-Harcourt, Rivers State, Nigeria.

Chidebe Christian Anikwe

Department of Obstetrics and Gynecology, Nnamdi Azikiwe University, Teaching Hospital Nnewi, Nigeria.

Nworah Josiah Azubike Obiechina

Department of Obstetrics and Gynecology, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria.

George Uchenna Eleje

Department of Obstetrics and Gynecology, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

Background: Retinoblastoma is a rare, curable but deadly intra ocular tumor affecting usually children under 5 years of age. Awareness, early detection and treatment determine vision preservation and patient’s survival. In low- and middle-income countries majority of children present very late because of poor awareness of early signs of retinoblastoma.

Aim: To determine the awareness and knowledge of retinoblastoma among pregnant women in Anambra State, Nigeria.

Methods: This study was a cross sectional  study that was carried out among 246 antenatal attendee in a private specialist hospital in Anambra state between March 2023 to August 2023. It was done using a validated, self-administered and interviewer-administered questionnaire which included 25 well-structured questions concerning awareness of retinoblastoma. Data obtained were analyzed using IBM SPSS version 26 statistical package. Participants' responses were anonymized and analyzed. Continuous variables were analyzed while bivariate analysis was done using chi-square whereas binary logistic regression analysis was performed to identify factors associated with retinoblastoma awareness. The test of significant was p-value <0.05.

Results: Two hundred and forty six women participated in this survey. Of the women who participated in this survey, 84.2% reported not having heard of retinoblastoma.  The majority heard it via health workers (40.0%). However, majority of the participants do not know that retinoblastoma can affect children (49.3%), or can be inherited from parents (63.3%). Multivariate logistic regression analysis identified two variables that might influence retinoblastoma awareness: occupation (trader) of the husband (adjusted odds ratio (aOR) = 2.63, 95% CI = 1.07-6.49; p=0.035) and childbearing (aOR=5.83, 95% CI = 1.14-9.20; p=0.046).

Conclusion: Nigerian pregnant women had appallingly low levels of awareness and information of retinoblastoma during pregnancy. There was a correlation between the participants' level of knowledge about retinoblastoma and their husband's occupation, and having children. These results could lead to improved ophthalmic practices and the development of successful public health programmes, ultimately benefiting the health of Nigerian pregnant women and children. It will take more research to examine this connection.

Keywords: Retinoblastoma, ocular tumor, pediatric eye cancer, cancer


How to Cite

Onwuegbuna , Arinze Anthony, Akunne Ijeoma Apakama, Emeka Akujuobi Chianakwalam, Chidiebele Malachy Ezeude, Bernard Chukwunonyerem Ochiogu, Anthonia Chinyelu Udeaja, Chisom God’swill Chigbo, Chidebe Christian Anikwe, Nworah Josiah Azubike Obiechina, and George Uchenna Eleje. 2024. “Awareness and Knowledge of Retinoblastoma Among Pregnant Women in Nigeria”. International Research Journal of Oncology 7 (1):87-97. https://www.journalirjo.com/index.php/IRJO/article/view/150.

Downloads

Download data is not yet available.

References

Rathore S, Verma A, Ratna R, Marwa N, Ghiya Y, Honavar SG, et al. Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies. Indian J Ophthalmol. 2023 Jul;71(7):2662-2676. DOI: 10.4103/IJO.IJO_3172_22.

Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, et al. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncol. 2020;6(5):685–95.

Naser AY, Alrawashdeh HM, Alwafi H, Alyami HS, Dahmash EZ, Ghoul I, et al. Knowledge and awareness of the general population and healthcare providers about retinoblastoma: It is time to know the glow. Int J Clin Pract. 2021 Aug;75(8):e14298. DOI: 10.1111/ijcp.14298.

Chawla B, Singh R. Recent advances and challenges in the management of retinoblastoma. Indian J Ophthalmol. 2017 Feb;65(2):133-139. DOI: 10.4103/ijo.IJO_883_16.

Robert Cronin Yung Peng, Rose Khavari ND. Retinoblastoma HHS Public Access. Physiol Behav. 2017;176(3):139–48.

Gregersen PA, Funding M, Alsner J, Olsen MH, Overgaard J, Urbak SF, et al. Living with heritable retinoblastoma and the perceived role of regular follow-up at a retinoblastoma survivorship clinic: 'That is exactly what I have been missing'. BMJ Open Ophthalmol. 2021 Sep 12;6(1): e000760. DOI: 10.1136/bmjophth-2021-000760.

Al-Nawaiseh I, Ghanem AQ, Yousef YA. Familial retinoblastoma: Raised awareness improves early diagnosis and outcome. J Ophthalmol. 2017;2017:5053961. DOI: 10.1155/2017/5053961.

Global Retinoblastoma Study Group. The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. Lancet Glob Health. 2022 Aug;10(8):e1128-e1140. DOI: 10.1016/S2214-109X(22)00250-9.

Atipo-Tsiba PW, Itoua C. Retinoblastoma: Assessing the level of knowledge of tumour by midwives in Brazzaville. East Afr Med J. 2015;92(5):241–4.

Coffie PA, Egger M, Vinikoor MJ, Zannou M, Diero L, Patassi A, et al. Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa. BMC Infect Dis. 2017;17(Suppl 1).

Yousef YA, AlNawaiseh T, AlJabari R, Muhsen S, Al-Nawaiseh I. Retinoblastoma awareness among first contact physicians in Jordan. Ophthalmic Genet. 2019 Jun;40(3):191-195.

DOI: 10.1080/13816810.2019.1605387.

Tomar AS, Finger PT, Gallie B, Kivelä TT, Mallipatna A, Zhang C, et al. Global Retinoblastoma Treatment Outcomes: Association with National Income Level. Ophthalmology. 2021 May;128(5):740-753.

DOI: 10.1016/j.ophtha.2020.09.032.

Badhu B, Sah SP, Thakur SKD, Dulal S, Kumar S, Sood A, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Exp Ophthalmol. 2005; 33(4):386–9.

Odashiro AN, Pereira PR, de Souza Filho JP, Cruess SR, Burnier MN., Jr Retinoblastoma in an adult: Case report and literature review. Can J Ophthalmol. 2005;40:188–91.

Nandedkar VS, Joshi AR, Kabra N, Deshpande NN. Presentation of retinoblastoma in pregnancy. Indian J Ophthalmol. 2010 May-Jun;58(3):229-32. doi: 10.4103/0301-4738.62649.

Takahashi T, Tamura S, Inoue M, Isayama Y, Sashikata T. Retinoblastoma in a 26-year-old adult. Ophthalmology. 1983;90:179–83.

Elfalah M, AlNawaiseh T, Atoum D, AlKhassawneh A, Mohammad M, AlNawaiseh I, et al. Improving Medical Students' Awareness About Retinoblastoma: A Practical Strategy. Clin Ophthalmol. 2022 Jun 7;16:1807-1814. DOI: 10.2147/OPTH.S355876.